GT Biopharma Inc (GTBP)
3.30
+0.10
(+3.29%)
USD |
NASDAQ |
May 03, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2015 | -293.1K% |
December 31, 2014 | -56.47K% |
September 30, 2014 | -140.7K% |
June 30, 2014 | -1.05K% |
March 31, 2014 | |
December 31, 2013 | -863.4% |
September 30, 2013 | -174.3% |
June 30, 2013 | -546.4% |
March 31, 2013 | |
December 31, 2012 | -347.5% |
September 30, 2012 | -1.17K% |
June 30, 2012 | -239.5K% |
March 31, 2012 | -61.50K% |
December 31, 2011 | -37.93K% |
September 30, 2011 | |
June 30, 2011 | -66.20K% |
March 31, 2011 | -9.62K% |
December 31, 2010 | -6.02K% |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | -10.28K% |
September 30, 2009 | |
June 30, 2009 | -1.01K% |
March 31, 2009 |
Date | Value |
---|---|
December 31, 2008 | -385.4% |
September 30, 2008 | -253.0% |
June 30, 2008 | -649.5% |
March 31, 2008 | -382.5% |
December 31, 2007 | 21.15% |
September 30, 2007 | -7.89% |
June 30, 2007 | 59.85% |
March 31, 2007 | -55.64% |
December 31, 2006 | -216.3% |
September 30, 2006 | -43.19% |
June 30, 2006 | -42.70% |
March 31, 2006 | -45.60% |
December 31, 2005 | -287.8% |
September 30, 2005 | -59.77% |
June 30, 2005 | -54.05% |
March 31, 2005 | -39.46% |
December 31, 2004 | -209.5% |
September 30, 2004 | -5.56% |
June 30, 2004 | -275.5% |
March 31, 2004 | -104.6% |
December 31, 2003 | -22.68% |
September 30, 2003 | -25.71% |
June 30, 2003 | -42.06% |
March 31, 2003 | -27.14% |
December 31, 2002 | -34.74% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Cutera Inc | -91.30% |
Outlook Therapeutics Inc | -- |
180 Life Sciences Corp | -- |
Journey Medical Corp | -14.05% |
NovaBay Pharmaceuticals Inc | -110.2% |